Results for:(123 found)
Nov 7, 2012 10:17PM on Top StocksBy Gene Marcial

The market's tumble Wednesday following the president's reelection offers a fresh and real chance to ride the bull market.

Oct 31, 2012 10:38AM on Top StocksBy InvestorPlace

The revenue in question seems too small to make a difference.

Oct 26, 2012 6:26AM on Top StocksBy Benzinga

As earnings season continues, two of the largest companies miss analyst expectations.

Oct 23, 2012 11:56AM on Top StocksBy Stock Traders Daily

The pharma's earnings may not look great, but bailing out could prove costly for investors if its Alzheimer's drug is successful.

Oct 18, 2012 11:43AM on Top StocksBy Stock Traders Daily

Although Abbott has recently gained on positive trial results, Gilead Sciences remains in the forefront of the market.

Aug 24, 2012 11:17AM on Top StocksBy MSN Money Partner

Autodesk is downgraded at 2 firms, and General Growth is downgraded to 'neutral.'

Aug 3, 2012 9:29AM on Top StocksBy TheStockAdvisors

Here's an easy, time-tested strategy to outperform the Dow industrials with a 5-stock portfolio.

Jul 12, 2012 12:52PM on Top StocksBy MSN Money Partner

Stocks pare earlier losses but remain down despite a drop in initial jobless claims. SVU tanks nearly 50%.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More